Australia markets closed

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.33-0.12 (-2.20%)
At close: 04:00PM EDT
5.33 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
78,323
111,272
85,061
57,155
24,005
Selling general and administrative
24,959
32,039
27,323
15,727
4,005
Total operating expenses
103,282
143,311
112,384
72,882
28,010
Operating income or loss
-103,282
-143,311
-112,384
-72,882
-28,010
Total other income/expenses net
336
-1,037
119
-1,122
-7,878
Income before tax
-101,159
-135,014
-108,501
-73,958
-35,879
Income tax expense
338
338
0
-
-
Income from continuing operations
-101,159
-135,352
-108,501
-73,958
-35,879
Net income
-101,159
-135,352
-108,501
-73,958
-35,879
Net income available to common shareholders
-101,159
-135,352
-108,501
-73,958
-35,879
Basic EPS
-2.30
-
-2.30
-2.96
-1.65
Diluted EPS
-2.30
-
-2.30
-2.96
-1.65
Basic average shares
47,227
-
47,227
25,000
21,738
Diluted average shares
47,227
-
47,227
25,000
21,738